PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14527871-7	2003	RESULTS: Treatment with 5-HTP significantly delayed hindlimb weakness and mortality in SOD1 G93A mice in a dose-dependent manner.	5-Hydroxytryptophan	24-29	superoxide dismutase 1, soluble	Mus musculus	87-91	
16861147-13	2006	In fact, 5HT1A and 5HT2 receptor agonists have been shown to prevent glutamate-induced neurotoxicity in primary cortical cell cultures and the 5-HT precursor 5-hydroxytryptophan (5-HTP) improved locomotor function and survival of transgenic SOD1 G93A mice, an animal model of ALS.	5-Hydroxytryptophan	158-177	superoxide dismutase 1, soluble	Mus musculus	241-245	
16861147-13	2006	In fact, 5HT1A and 5HT2 receptor agonists have been shown to prevent glutamate-induced neurotoxicity in primary cortical cell cultures and the 5-HT precursor 5-hydroxytryptophan (5-HTP) improved locomotor function and survival of transgenic SOD1 G93A mice, an animal model of ALS.	5-Hydroxytryptophan	179-184	superoxide dismutase 1, soluble	Mus musculus	241-245	
14527871-11	2003	CONCLUSIONS: Increased blood serotonin by administration of 5-HTP in SOD1 G93A mice led to improved locomotor function and survival.	5-Hydroxytryptophan	60-65	superoxide dismutase 1, soluble	Mus musculus	69-73